Literature DB >> 20199890

Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.

Jordi B Torrelles1, Larry S Schlesinger.   

Abstract

Mycobacterium tuberculosis (the causal agent of TB) has co-evolved with humans for centuries. It infects via the airborne route and is a prototypic highly adapted intracellular pathogen of macrophages. Extensive sequencing of the M. tuberculosis genome along with recent molecular phylogenetic studies is enabling us to gain insight into the biologic diversity that exists among bacterial strains that impact the pathogenesis of latent infection and disease. The majority of the M. tuberculosis cell envelope is comprised of carbohydrates and lipids, and there is increasing evidence that these microbial determinants that are readily exposed to the host immune system play critical roles in disease pathogenesis. Studies from our laboratory and others have raised the possibility that M. tuberculosis is adapting to the human host by cloaking its cell envelope molecules with terminal mannosylated (i.e. Man-alpha-(1-->2)-Man) oligosaccharides that resemble the glycoforms of mammalian mannoproteins. These mannosylated biomolecules engage the mannose receptor (MR) on macrophages during phagocytosis and dictate the intracellular fate of M. tuberculosis by regulating formation of the unique vesicular compartment in which the bacterium survives. The MR is highly expressed on alveolar macrophages (predominant C-type lectin on human cells) and functions as a scavenger receptor to maintain the healthiness of the lung by clearing foreign particles and at the same time regulating dangerous inflammatory responses. Thus M. tuberculosis exploits MR functions to gain entry into the macrophage and survive. Key biochemical pathways and mycobacterial determinants involved in the development and maintenance of the M. tuberculosis phagosome are being identified. The phylogenetic diversity observed in M. tuberculosis strains that impact its cell wall structure together with the genetic diversity observed in human populations, including those elements that affect macrophage function, may help to explain the extraordinary evolutionary adaptation of this pathogen to the human host. Major developments in these areas are the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199890      PMCID: PMC2855779          DOI: 10.1016/j.tube.2010.02.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  118 in total

1.  6-O-METHYL-D-GLUCOSE FROM MYCOBACTERIA.

Authors:  Y C LEE; C E BALLOU
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

Review 2.  Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects.

Authors:  D Chatterjee; K H Khoo
Journal:  Glycobiology       Date:  1998-02       Impact factor: 4.313

Review 3.  The envelope layers of mycobacteria with reference to their pathogenicity.

Authors:  M Daffé; P Draper
Journal:  Adv Microb Physiol       Date:  1998       Impact factor: 3.517

Review 4.  Mechanisms of mycobacterial persistence in tuberculosis.

Authors:  David J Kusner
Journal:  Clin Immunol       Date:  2005-03       Impact factor: 3.969

5.  Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling.

Authors:  A K Shabaana; K Kulangara; I Semac; Y Parel; S Ilangumaran; K Dharmalingam; C Chizzolini; D C Hoessli
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

6.  Coming of age: carbohydrates and immunity.

Authors:  Brian A Cobb; Dennis L Kasper
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

7.  Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells.

Authors:  D B Moody; B B Reinhold; V N Reinhold; G S Besra; S A Porcelli
Journal:  Immunol Lett       Date:  1999-01       Impact factor: 3.685

8.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor.

Authors:  M Gilleron; J Nigou; B Cahuzac; G Puzo
Journal:  J Mol Biol       Date:  1999-02-05       Impact factor: 5.469

10.  THE PARTICULATE HYDROLASES OF MACROPHAGES. I. COMPARATIVE ENZYMOLOGY, ISOLATION, AND PROPERTIES.

Authors:  Z A COHN; E WIENER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  69 in total

Review 1.  Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria.

Authors:  Marcelo E Guerin; Jana Korduláková; Pedro M Alzari; Patrick J Brennan; Mary Jackson
Journal:  J Biol Chem       Date:  2010-08-27       Impact factor: 5.157

2.  Deoxysugars as antituberculars and alpha-mannosidase inhibitors.

Authors:  Vivek Kashyap; Smriti Sharma; Vinayak Singh; Sandeep K Sharma; Mohammad Saquib; Ranjana Srivastava; Arun K Shaw
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

3.  Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells.

Authors:  Jordi B Torrelles; Peter A Sieling; Nannan Zhang; Mark A Keen; Michael R McNeil; John T Belisle; Robert L Modlin; Patrick J Brennan; Delphi Chatterjee
Journal:  Glycobiology       Date:  2012-04-25       Impact factor: 4.313

4.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

5.  Biosynthesis of the Methylthioxylose Capping Motif of Lipoarabinomannan in Mycobacterium tuberculosis.

Authors:  Shiva Kumar Angala; Michael R McNeil; Libin Shi; Maju Joe; Ha Pham; Sophie Zuberogoitia; Jérôme Nigou; Claudia M Boot; Todd L Lowary; Martine Gilleron; Mary Jackson
Journal:  ACS Chem Biol       Date:  2017-01-20       Impact factor: 5.100

Review 6.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 7.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

8.  Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannoside.

Authors:  Zuzana Svetlíková; Peter Baráth; Mary Jackson; Jana Korduláková; Katarína Mikušová
Journal:  Protein Expr Purif       Date:  2014-05-06       Impact factor: 1.650

9.  Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages.

Authors:  Nadia L Ferrer; Ana B Gomez; Olivier Neyrolles; Brigitte Gicquel; Carlos Martin
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

10.  The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway.

Authors:  Amro Bohsali; Hana Abdalla; Kamalakannan Velmurugan; Volker Briken
Journal:  BMC Microbiol       Date:  2010-09-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.